Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation
Event:
ESC Congress 2019
Topic:
Oral Anticoagulation
Session:
Atrial fibrillation and oral anticoagulation 5